CymitQuimica logo

CAS 10118-85-1

:

Lidimycin

Description:
Lidimycin, with the CAS number 10118-85-1, is an antibiotic compound that belongs to the class of macrolides. It is primarily derived from the fermentation of certain strains of Streptomyces bacteria. Lidimycin exhibits antibacterial properties, making it effective against a range of Gram-positive bacteria, including some strains that are resistant to other antibiotics. The mechanism of action involves the inhibition of protein synthesis by binding to the bacterial ribosome, thereby preventing the growth and reproduction of the bacteria. In addition to its antibacterial activity, Lidimycin has been studied for its potential antitumor effects, although its clinical use may be limited due to toxicity and side effects. The compound is typically administered in a controlled setting, and its pharmacokinetics, including absorption, distribution, metabolism, and excretion, are important for determining its therapeutic efficacy and safety profile. As with many antibiotics, the emergence of resistance is a concern, necessitating careful use and ongoing research into its applications.
Formula:C10H14N2O3S
InChI:InChI=1/C10H14N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h2,4,6-7,9H,1,3,5H2,(H,13,14)(H2,11,12,15)/b4-2+/t6-,7-,9-/m0/s1
Synonyms:
  • (2E)-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pent-2-enoic acid
  • (2E)-5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pent-2-enoic acid
  • alpha-Dehydrobiotin
  • Lydimycin
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.